Difference between revisions of "Atovaquone (Mepron)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - " " to " ")
(17 intermediate revisions by 5 users not shown)
Line 1: Line 1:
 
 
==General information==
 
==General information==
Class/mechanism: Antiprotozoal, antimicrobial. Hydroxy-1,4-naphthoquinone, analog of ubiquinone, with antipneumocystis activity. Exact mechanism unclear, but may involve inhibition of the electron transport chain in mitochondria and downstream inhibition of nucleic acid and ATP synthesis.<ref name="insert">[http://us.gsk.com/products/assets/us_mepron.pdf Atovaquone (Mepron) package insert]</ref><ref>[http://hemonc.org/docs/chemotherapypackageinsert/atovaquone.pdf Atovaquone (Mepron) package insert (locally hosted backup)]</ref>
+
Class/mechanism: Antiprotozoal, antimicrobial. Hydroxy-1,4-naphthoquinone, analog of ubiquinone, with antipneumocystis activity. Exact mechanism unclear, but may involve inhibition of the electron transport chain in mitochondria and downstream inhibition of nucleic acid and ATP synthesis.<ref name="insert">[https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Mepron/pdf/MEPRON.PDF Atovaquone (Mepron) package insert]</ref><ref>[[:File:Atovaquone.pdf | Atovaquone (Mepron) package insert (locally hosted backup)]]</ref>
 
<br>Route: PO (typically as liquid suspension)
 
<br>Route: PO (typically as liquid suspension)
 
<br>Extravasation: n/a
 
<br>Extravasation: n/a
  
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the package insert<ref name="insert"></ref>.
+
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://reference.medscape.com/drug/mepron-atovaquone-342686 Medscape], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 +
 
 +
==Diseases for which it is used==
 +
''No known antineoplastic properties.''
  
 
==Patient drug information==
 
==Patient drug information==
 
*[http://www.uptodate.com/contents/atovaquone-patient-drug-information Atovaquone (Mepron) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/atovaquone-patient-drug-information Atovaquone (Mepron) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/atovaquone-patient-drug-information Atovaquone (Mepron) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/atovaquone-patient-drug-information Atovaquone (Mepron) patient drug information (UpToDate)]</ref>
  
==Regimens==
+
==Also known as==
Standard format will be:
+
*'''Brand name:''' Mepron
<br><acronym (if any)> <generic drug1, generic drug2, generic drug3, etc.> (disease)
 
  
 
==References==
 
==References==
 
<references/>
 
<references/>
 +
 +
[[Category:Drugs]]
 +
[[Category:Oral medications]]
 +
 +
[[Category:PCP prophylaxis]]
 +
 +
[[Category:FDA approved in 1992]]

Revision as of 01:42, 1 June 2023

General information

Class/mechanism: Antiprotozoal, antimicrobial. Hydroxy-1,4-naphthoquinone, analog of ubiquinone, with antipneumocystis activity. Exact mechanism unclear, but may involve inhibition of the electron transport chain in mitochondria and downstream inhibition of nucleic acid and ATP synthesis.[1][2]
Route: PO (typically as liquid suspension)
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, Medscape, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

No known antineoplastic properties.

Patient drug information

Also known as

  • Brand name: Mepron

References